STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
RegulatoryMay 4, 2026, 05:13 PM

Jaguar Health Cures Nasdaq Publicly Held Shares Non-Compliance

AI Summary

Jaguar Health, Inc. received a Nasdaq notification on May 1, 2026, for non-compliance with the minimum 500,000 Publicly Held Shares Requirement, following a 1-for-35 reverse stock split that reduced publicly held shares to approximately 401,226. The company also remained non-compliant with the $1.00 bid price requirement. On May 4, 2026, the exercise of pre-funded warrants increased publicly held shares to 513,939, bringing the company into compliance with the Publicly Held Shares Requirement. Jaguar Health is now awaiting formal confirmation from Nasdaq.

Key Highlights

  • Jaguar Health received a Nasdaq notice for non-compliance with the 500,000 Publicly Held Shares Requirement.
  • Post 1-for-35 reverse stock split, publicly held shares were approximately 401,226.
  • The company also remained non-compliant with the minimum $1.00 bid price requirement.
  • On May 4, 2026, certain investors exercised pre-funded warrants.
  • This resulted in 513,939 publicly held shares, exceeding the 500,000 minimum.
  • Jaguar Health is awaiting Nasdaq's formal confirmation of compliance for publicly held shares.
JAGX
Biotechnology: Pharmaceutical Preparations
Jaguar Health, Inc.

Price Impact